Steplewski, Klaudia
Walker, Lucy
Coffee, Nefeteria https://orcid.org/0009-0003-3607-1572
Fallon, Maura
Yonemochi, Rie
Alpers, David
Rockey, Don
Lewis, James
Cohen, Eric
Caminis, John
Hey-Hadavi, Judith
Andrade, Raul Jesus
Palmer, Melissa
Article History
Accepted: 20 February 2025
First Online: 3 April 2025
Declarations
:
: The authors received no financial support for the research, authorship, and publication of this manuscript.
: James Lewis is an editorial board member of Drug Safety and was not involved in the selection of peer reviewers for the manuscript or any of the subsequent editorial decisions. All other authors have no competing interests to declare that are relevant to the content of this article.
: No ethics approvals were required for this manuscript. The survey was developed and conducted under the auspices of the IQ Consortium and IQ DILI Initiative in accordance with the organization’s established data sharing guidelines.
: Not applicable.
: Not applicable.
: The data that went into the drafting of this manuscript are provided as references and in the ESM. Data sharing is not applicable to this article.
: Not applicable.
: Conceptualization and initial drafting of the manuscript: Klaudia Steplewski and Melissa Palmer. All authors contributed to the manuscript in accordance with the guidance. All authors read and approved the final version.